Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.98M | -8.28M | -9.17M | -13.56M | -16.44M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | 794.20K | 1.27M | 1.27M |
| Total Other Non-Cash Items | -297.80K | 4.51M | 4.03M | 4.04M | -161.50K |
| Change in Net Operating Assets | 1.71M | 493.00K | 247.80K | 2.09M | -379.80K |
| Cash from Operations | -1.58M | -3.27M | -4.09M | -6.16M | -15.72M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -132.10K | -132.10K | -132.10K | -732.10K | -600.00K |
| Cash from Investing | -132.10K | -132.10K | -132.10K | -732.10K | -600.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -526.20K | -3.37M | -3.21M | -3.05M | -2.90M |
| Issuance of Common Stock | 250.00K | 9.00M | 9.00M | 11.50M | 11.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -802.60K | -802.60K | -802.60K | -802.60K |
| Cash from Financing | -276.20K | 4.83M | 4.99M | 7.64M | 7.80M |
| Foreign Exchange rate Adjustments | -- | -- | 62.20K | 62.20K | 400.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.98M | 1.42M | 824.00K | 809.40K | -8.52M |